Warren buffett should buy $Medifast(MED)$.MED is one of the stocks to buy, with a market capitalization of about $2 billion, and boasts the highest dividend on the list at 3.6%. Trading at a measly 13 times earnings, MED's business appears undervalued, especially given an immaculate balance sheet, a long track record of growth, and expected revenue growth of 15% and 13.7% in 2022 and 2023. Medifast hiked its dividend payout by 15% in March. For investors seeking an under-the-radar stock with big upside potential, Medifast shares have roughly 87% upside to their 52-week highs.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments